Mind Medicine (MindMed) Inc.
MNMD
Price:
$20.69
Market Cap:
$2.70B
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering new treatments for various brain health conditions, encompassing psychiatric disorders, addiction, pain, and neurological ailments. Among its key pipeline assets is MM-120, currently undergoing Phase 2 clinical trials. This candidate is being investigated for its potential in addressing generalized anxiety disorder, attention deficit hyperactivity disorder (ADHD), and chronic pain. Furthermore, MM-110, an a3ß4 nicotinic cholinergic receptor antagonist, has successfully completed Phase 1 studies for managing opioid withdrawal. The company's portfolio also includes MM-402, an R-enantiomer of 3,4-met...[Read more]
Industry
Biotechnology
IPO Date
2016-11-15
Stock Exchange
NASDAQ
Ticker
MNMD
PE Ratio
[-10.45]
ROE
[-102.48%]
Current Ratio
[4.69]
Dividend Yield
[0%]
Enterprise Value
[2.44B]
Dividend History
The Enterprise Value as of June 2026 (TTM) for Mind Medicine (MindMed) Inc. (MNMD) is 2.44B
According to Mind Medicine (MindMed) Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.44B. This represents a change of 125.29% compared to the average of 1.08B of the last 4 quarters.
Mind Medicine (MindMed) Inc. (MNMD) Historical Enterprise Value (quarterly & annually)
How has MNMD Enterprise Value performed in the past?
The mean historical Enterprise Value of Mind Medicine (MindMed) Inc. over the last ten years is 232.77M. The current 2.44B Enterprise Value has changed 104.59% with respect to the historical average. Over the past ten years (40 quarters), MNMD's Enterprise Value was at its highest in in the March 2026 quarter at 1.79B. The Enterprise Value was at its lowest in in the December 2022 quarter at -58515900.80.
Average
232.77M
Median
29.60M
Minimum
-74183581.40
Maximum
938.26M
Mind Medicine (MindMed) Inc. (MNMD) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Mind Medicine (MindMed) Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 293.18%
Maximum Annual Enterprise Value = 938.26M
Minimum Annual Increase = -177.84%
Minimum Annual Enterprise Value = -74183581.40
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 938.26M | 293.36% |
| 2024 | 238.52M | 313.09% |
| 2023 | 57.74M | -177.84% |
| 2022 | -74183581.40 | -117.13% |
| 2021 | 433.17M | -40.81% |
| 2020 | 731.88M | 293.18% |
| 2019 | 249.55K | -20.53% |
| 2018 | 314.03K | -78.35% |
| 2017 | 1.45M | 456.00% |
| 2016 | 260.84K | -0.59% |
Mind Medicine (MindMed) Inc. (MNMD) Average Enterprise Value
How has MNMD Enterprise Value performed in the past?
The current Enterprise Value of Mind Medicine (MindMed) Inc. (MNMD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
411.51M
5-year avg
318.70M
10-year avg
232.77M
Mind Medicine (MindMed) Inc. (MNMD) Enterprise Value vs. Peers
How is MNMD’s Enterprise Value compared to its peers?
Mind Medicine (MindMed) Inc.’s Enterprise Value is greater than UroGen Pharma Ltd. (1.53B), greater than BridgeBio Oncology Therapeutics Inc. (570.82M), less than Tango Therapeutics, Inc. (3.73B), less than AnaptysBio, Inc. (2.45B), greater than Rezolute, Inc. (375.04M), greater than Xencor, Inc. (1.08B), greater than Nurix Therapeutics, Inc. (1.46B), greater than Fortrea Holdings Inc. (1.49B), greater than Kodiak Sciences Inc. (1.79B), greater than Savara Inc. (1.07B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.53B | $1.45B | |
| 570.82M | $620.83M | |
| 3.73B | $3.85B | |
| 2.45B | $2.42B | |
| 375.04M | $385.17M | |
| 1.08B | $914.17M | |
| 1.46B | $1.47B | |
| 1.49B | $1.56B | |
| 1.79B | $1.80B | |
| 1.07B | $1.08B |
Build a custom stock screener for Mind Medicine (MindMed) Inc. (MNMD) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mind Medicine (MindMed) Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Mind Medicine (MindMed) Inc. (MNMD) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Mind Medicine (MindMed) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Mind Medicine (MindMed) Inc.'s Enterprise Value?
What is the highest Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?
What is the 3-year average Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?
What is the 5-year average Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD)?
How does the current Enterprise Value for Mind Medicine (MindMed) Inc. (MNMD) compare to its historical average?